Japan Biopharma
Partnering Conference

Conrad Hotel
Tokyo, Japan
October 14, 2014

Program

We designed the conference to give all attendees an opportunity to meet with presenters. The agenda begins with a welcome from Sofinnova Ventures, followed by sessions from the presenting companies. The schedule below will be completed in the coming months as we finalize all presenting companies. Please check back to find an updated agenda.

October 14th, 2014 Track A (Nami) Track B (Nagisa)
7:30 a.m. – 8:30 a.m. Continental Breakfast and Registration
8:30 a.m. – 8:45 a.m. Welcome (Nami)
Anand Mehra, MD, Partner, Sofinnova Ventures
8:45 a.m.
9:05 a.m.
9:25 a.m.
9:45 a.m.
10:05 a.m.
10:25 a.m.
Spitfire Pharma, Inc.
ObsEva SA
Spectrum Pharmaceuticals
Tobira Therapeutics
CoDA Therapeutics
Aldea Pharmaceuticals
Mirna Therapeutics
Aeglea BioTherapeutics
Avidity NanoMedicines
BIND Therapeutics
Dicerna Pharmaceuticals
Igenica Biotherapeutics
10:45 a.m. – 11:05 a.m. Break & Networking
11:05 a.m.
11:25 a.m.
11:45 p.m.
12:05 p.m.
12:25 p.m.
Cebix
Kona Medical
Juventas Therapeutics
Promethera Biosciences
Histogen
Ignyta
Mersana Therapeutics
Tigercat Pharma
NuCana BioMed
Verastem
12:45 p.m. – 1:25 p.m. Lunch (Nagi on 2nd Floor)
1:20 p.m. Remarks
Sougoto Das, Director, Partnering Products & Services, Business Development, BIO
1:30 p.m. Presentation (Nami)
Aradhana Sarin MD, Managing Director, Healthcare Investment Banking, NY Office, Citigroup Global Markets
"IPO/M&A trend in US BioPharma sector"
1:45 p.m. Presentation (Nami)
Ray Fujii, Partner, L.E.K Consulting
"Partnering Landscape and Strategy"
2:00 p.m. – 2:50 p.m. Lunch Presentation and Panel (Nami)
Moderated by David Kabakoff, PhD, Executive Partner, Sofinnova Ventures
"Trend in Oncology R&D" (Tentative)
2:50 p.m.
3:10 p.m.
3:30 p.m.
3:50 p.m.
4:10 p.m.
Auspex Pharmaceuticals
Alcobra
Insmed
Durata Therapeutics
NOXXON Pharma
Principia Biopharma
Terpenoid Therapeutics
Hookipa
KineMed
JHL Biotech
4:30 p.m. – 4:50 p.m. Break & Networking
4:50 p.m.
5:10 p.m.
5:30 p.m.
5:50 p.m.
6:10 p.m.
Concert Pharmaceuticals
Ocera Therapeutics
Inovio
Crescendo Biologics
Neurocrine Biosciences
ASLAN Pharmaceuticals
Genscript Corporation
Zai Laboratory
ImaginAb
Biovest
6:30 p.m. – 8:30 p.m. Cocktail Reception (Lounge TwentyEight, across from the Conrad lobby)
  • Event
  • Event
  • Event
  • Event
  • Event